Long-term remission in a patient with carcinoma of unknown primary site

Chemotherapy. 2006;52(1):12-5. doi: 10.1159/000090235. Epub 2005 Dec 9.

Abstract

Background: Cancer of unknown primary site also designated as CUP syndrome usually presents as metastatic disease with a poor prognosis and low remission as well as survival rates.

Case: We report a 46-year-old male with para-aortal and left-sided cervical lymph node metastases. Histological examination of a cervical lymph node revealed papillary carcinoma. Despite thorough investigation, no primary tumor was found. The patient was empirically treated with six courses of the FACP regimen (5-fluorouracil, Adriamycin, cyclophosphamide and cisplatin) combined with radiotherapy (40 Gy) and has remained in complete remission for 124 months.

Conclusion: This case indicates that treatment of a patient with cancer of unknown primary site may be rewarded by a benign course. However, complete cure remains a very rare event in CUP. Remission can be achieved with a platinum-containing regimen combined with radiotherapy.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma / drug therapy*
  • Carcinoma / pathology*
  • Cisplatin / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Humans
  • Lymph Nodes / pathology
  • Male
  • Middle Aged
  • Neoplasms, Unknown Primary / drug therapy*
  • Neoplasms, Unknown Primary / pathology*
  • Remission Induction
  • Tegafur / therapeutic use
  • Time Factors
  • Tomography Scanners, X-Ray Computed

Substances

  • Tegafur
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin

Supplementary concepts

  • FACP protocol